Bucher Pascal, Taylor Sophia, Villiger Peter, Morel Philippe, Brundler Marie Anne
Department of Surgery, University Hospital of Geneva, 24, Rue Micheli-du-Crest, 1211, Geneva 14, Switzerland.
Am J Surg. 2004 Jun;187(6):761-6. doi: 10.1016/j.amjsurg.2003.09.010.
Stromal tumors of the digestive tract, or gastrointestinal stromal tumors (GIST), originate from an intestinal mesenchymal precursor cell. Criteria that predict the outcome of small intestinal stromal tumors (SIST) after surgical resection are not clearly established. The aim of the study was to define prognostic criteria for SIST.
All c-kit positive SIST treated in our center over a 10-year period were reviewed.
Eighteen patients with SIST treated by surgical resection were included. Overall actuarial 5-year survival was 74% (median follow-up of 69 months). We developed a panel of five criteria (tumor size, mitotic rate, proliferation index, presence of necrosis, and invasion of mucosa or adjacent structures) that permitted distinction between low and high malignant potential SIST. Presence of any four of these five criteria defined a high malignant potential SIST, and was associated with disease recurrence and poor prognosis after surgical resection (P <0.01). Patients with low malignant potential SIST had a 5-year survival of 92%, compared with 0% for high malignant potential SIST (P <0.01).
This study demonstrates that a panel of morphologic factors can reliably distinguish between low and high malignant potential SIST. Although patients with low malignant potential SIST have an excellent prognosis after surgical resection, the role of adjuvant treatment for high malignant potential SIST remains to be defined.
消化道间质瘤,即胃肠道间质瘤(GIST),起源于肠道间充质前体细胞。目前尚未明确建立预测小肠间质瘤(SIST)手术切除后预后的标准。本研究的目的是确定SIST的预后标准。
回顾了本中心10年间治疗的所有c-kit阳性SIST。
纳入18例接受手术切除的SIST患者。总体5年精算生存率为74%(中位随访69个月)。我们制定了一组五项标准(肿瘤大小、有丝分裂率、增殖指数、坏死情况以及黏膜或相邻结构侵犯情况),可用于区分低恶性潜能和高恶性潜能的SIST。这五项标准中出现任何四项即定义为高恶性潜能SIST,与手术切除后疾病复发及预后不良相关(P<0.01)。低恶性潜能SIST患者的5年生存率为92%,而高恶性潜能SIST患者为0%(P<0.01)。
本研究表明,一组形态学因素能够可靠地区分低恶性潜能和高恶性潜能的SIST。尽管低恶性潜能SIST患者手术切除后预后良好,但高恶性潜能SIST辅助治疗的作用仍有待确定。